S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
Log in

CVE:OGI - OrganiGram Stock Price, Forecast & News

Today's Range N/A
50-Day Range
C$6.22
MA: C$6.22
C$6.22
52-Week Range N/A
Volume671,781 shs
Average Volume1.32 million shs
Market CapitalizationC$661.23 million
P/E Ratio28.02
Dividend YieldN/A
BetaN/A
OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryCannabis
SectorMedical
CUSIPN/A
CIKN/A
Phone844-644-4726

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$67.32 million
Book ValueC$2.19 per share

Profitability

Miscellaneous

Employees356
Market CapC$661.23 million
Next Earnings DateN/A
OptionableNot Optionable

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.


OrganiGram (CVE:OGI) Frequently Asked Questions

What is OrganiGram's stock symbol?

OrganiGram trades on the Canadian Venture Exchange (CVE) under the ticker symbol "OGI."

What price target have analysts set for OGI?

6 analysts have issued 12-month price objectives for OrganiGram's stock. Their forecasts range from C$4.50 to C$9.00. On average, they expect OrganiGram's stock price to reach C$6.50 in the next twelve months. View Analyst Price Targets for OrganiGram.

What is the consensus analysts' recommendation for OrganiGram?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OrganiGram.

Has OrganiGram been receiving favorable news coverage?

Media stories about OGI stock have been trending very negative on Tuesday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. OrganiGram earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for OrganiGram.

Who are some of OrganiGram's key competitors?

What other stocks do shareholders of OrganiGram own?

Who are OrganiGram's key executives?

OrganiGram's management team includes the folowing people:
  • Mr. Greg Engel, CEO & Director (Age 54)
  • Mr. Paolo De Luca C.A., C.F.A, Chief Financial Officer (Age 46)
  • Mr. Jeff Purcell, VP - Operations
  • Mr. Michael David Tripp, Chief Legal Officer
  • Mr. Tim Emberg, VP of Sales & Commercial Operations

How do I buy shares of OrganiGram?

Shares of OGI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How big of a company is OrganiGram?

OrganiGram has a market capitalization of C$0.00 and generates C$67.32 million in revenue each year. OrganiGram employs 356 workers across the globe.View Additional Information About OrganiGram.

What is OrganiGram's official website?

The official website for OrganiGram is http://www.organigram.ca/.

How can I contact OrganiGram?

The company can be reached via phone at 844-644-4726.


MarketBeat Community Rating for OrganiGram (CVE OGI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  422 (Vote Outperform)
Underperform Votes:  385 (Vote Underperform)
Total Votes:  807
MarketBeat's community ratings are surveys of what our community members think about OrganiGram and other stocks. Vote "Outperform" if you believe OGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel